Antibodies increase the risk of poor outcome for patients with autoimmune hepatitis.

 

Related Articles

Antibodies increase the risk of poor outcome for patients with autoimmune hepatitis.

Nurs Stand. 2015 Sep 9;30(2):14

Authors:

Abstract
The presence of antibodies for the soluble liver antigen/liver pancreas antigen (SLA/LP) is a major risk factor for poor outcomes in patients with autoimmune hepatitis, say German researchers.

PMID: 26350841 [PubMed – in process]

http://www.ncbi.nlm.nih.gov/pubmed/26350841?dopt=Abstract

Leave a Reply

Your email address will not be published. Required fields are marked *